2015 annual financial data
Atossa Therapeutics 2015 Operating margin
Direct answer
Operating margin was -725,746.19%.
Operating income was -12,758,618 USD and net income was -15,760,323 USD.
Operating cash flow was -13,953,296 USD.
Get free Atossa Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,758 USD
- Operating income
- -12,758,618 USD
- Net income
- -15,760,323 USD
- Operating cash flow
- -13,953,296 USD